• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST PST; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST PST; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 07671687019
Device Problems No Device Output (1435); High Test Results (2457); Output Problem (3005)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/12/2023
Event Type  malfunction  
Manufacturer Narrative
The meter and strips were requested for investigation.The product has not been received at this time.If the product is returned in the future, a follow up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.".
 
Event Description
There was an allegation of questionable results from coaguchek inrange meter, serial number (b)(6), compared to a laboratory result using an unknown method.The meter result was 3.0 inr.The laboratory result was 5.0 inr.A second roche coagulation meter gave a result of 5.0 inr.The patient¿s therapeutic range is 2.5 - 3.0 inr.
 
Manufacturer Narrative
The customer's meter and test strips were provided for investigation where they were tested using retention controls.Testing results (qc range = 2.4 - 3.6 inr): qc 1: 2.8 inr.Qc 2: 3.0 inr.Qc 3: 2.9 inr.The customer's meter was also tested with retention strips using retention controls.Testing results (qc range = 2.4 - 3.6 inr): qc 1: 2.9 inr in two additional measurements with retention strips, error message e-64 was triggered.Per product labeling, "meter error [e-64]; test strip reader error.Power meter off and on.If error persists, contact roche diagnostics." the obtained qc values were in the allowed range of the used combination strip lot - qc lot.The reported result of 3.0 inr was found with on the following dates in the result memory log: (b)(6) 2023, (b)(6) 2023, (b)(6) 2022, and (b)(6) 2021.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST PST
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18464448
MDR Text Key332312573
Report Number1823260-2024-00071
Device Sequence Number1
Product Code GJS
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 02/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number07671687019
Device Lot Number65779412
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Manufacturer Received 12/14/2023
Initial Date FDA Received01/08/2024
Supplement Dates Manufacturer Received02/14/2024
Supplement Dates FDA Received02/29/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
WARFARIN
Patient SexMale
-
-